Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH

被引:68
作者
Bedi, Brahmchetna [1 ,2 ]
Li, Jau-Yi [1 ]
Tawfeek, Hesham [1 ]
Baek, Ki-Hyun [1 ]
Adams, Jonathan [1 ]
Vangara, Sameera S. [1 ]
Chang, Ming-Kang [3 ]
Kneissel, Michaela [3 ]
Weitzmanna, M. Neale [1 ,2 ]
Pacifici, Roberto [1 ,4 ]
机构
[1] Emory Univ, Dept Med, Div Endocrinol Metab & Lipids, Atlanta, GA 30322 USA
[2] Atlanta Vet Affairs Med Ctr, Decatur, GA 30033 USA
[3] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland
[4] Emory Univ, Immunol & Mol Pathogenesis Program, Atlanta, GA 30322 USA
基金
美国国家卫生研究院;
关键词
bone mass; T lymphocytes; bone cells; MESENCHYMAL STEM-CELLS; BETA-CATENIN; DIFFERENTIATED OSTEOBLASTS; TUBEROINFUNDIBULAR PEPTIDE; POSTMENOPAUSAL WOMEN; OSTEOCLAST FORMATION; GENE-EXPRESSION; CD40; LIGAND; IN-VIVO; WNT;
D O I
10.1073/pnas.1120735109
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Intermittent parathyroid hormone (iPTH) treatment stimulates T-cell production of the osteogenic Wnt ligand Wnt10b, a factor required for iPTH to activate Wnt signaling in osteoblasts and stimulate bone formation. However, it is unknown whether iPTH induces Wnt10b production and bone anabolism through direct activation of the parathyroid hormone (PTH)/PTH-related protein receptor (PPR) in T cells. Here, we show that conditional silencing of PPR in T cells blunts the capacity of iPTH to induce T-cell production of Wnt10b; activate Wnt signaling in osteoblasts; expand the osteoblastic pool; and increase bone turnover, bone mineral density, and trabecular bone volume. These findings demonstrate that direct PPR signaling in T cells plays an important role in PTH-induced bone anabolism by promoting T-cell production of Wnt10b and suggest that T cells may provide pharmacological targets for bone anabolism.
引用
收藏
页码:E725 / E733
页数:9
相关论文
共 58 条
[1]
CD40 ligand blocks apoptosis induced by tumor necrosis factor α, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4 [J].
Ahuja, SS ;
Zhao, SJ ;
Bellido, T ;
Plotkin, LI ;
Jimenez, F ;
Bonewald, LF .
ENDOCRINOLOGY, 2003, 144 (05) :1761-1769
[2]
Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by β-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT [J].
Almeida, M ;
Han, L ;
Bellido, T ;
Manolagas, SC ;
Kousteni, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (50) :41342-41351
[3]
Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts - A putative explanation for why intermittent administration is needed for bone anabolism [J].
Bellido, T ;
Ali, AA ;
Plotkin, LI ;
Fu, Q ;
Gubrij, I ;
Roberson, PK ;
Weinstein, RS ;
O'Brien, CA ;
Manolagas, SC ;
Jilka, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (50) :50259-50272
[4]
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis [J].
Bellido, T ;
Ali, AA ;
Gubrij, I ;
Plotkin, LI ;
Fu, Q ;
O'Brien, CA ;
Manolagas, SC ;
Jilka, RL .
ENDOCRINOLOGY, 2005, 146 (11) :4577-4583
[5]
Regulation of osteoblastogenesis and bone mass by Wnt10b [J].
Bennett, CN ;
Longo, KA ;
Wright, WS ;
Suva, LJ ;
Lane, TF ;
Hankenson, KD ;
MacDougald, OA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (09) :3324-3329
[6]
Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone [J].
Bikle, DD ;
Sakata, T ;
Leary, C ;
Elalieh, H ;
Ginzinger, D ;
Rosen, CJ ;
Beamer, W ;
Majumdar, S ;
Halloran, BP .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (09) :1570-1578
[7]
Wnt signaling and osteoblastogenesis [J].
Bodine, Peter V. N. ;
Komm, Barry S. .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2006, 7 (1-2) :33-39
[8]
The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis [J].
Bodine, PVN ;
Billiard, J ;
Moran, RA ;
Ponce-de-Leon, H ;
McLarney, S ;
Mangine, A ;
Scrimo, MJ ;
Bhat, RA ;
Stauffer, B ;
Green, J ;
Stein, GS ;
Lian, JB ;
Komm, BS .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2005, 96 (06) :1212-1230
[9]
Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone [J].
Calvi, LM ;
Sims, NA ;
Hunzelman, JL ;
Knight, MC ;
Giovannetti, A ;
Saxton, JM ;
Kronenberg, HM ;
Baron, R ;
Schipani, E .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) :277-286
[10]
Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-γ-induced class II transactivator [J].
Cenci, S ;
Toraldo, G ;
Weitzmann, MN ;
Roggia, C ;
Gao, YH ;
Qian, WP ;
Sierra, O ;
Pacifici, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (18) :10405-10410